GLP-1 agonists are transforming the weight loss market. Experts weighed in on the changes they’re seeing, speaking in a panel discussion during the MedCity News INVEST Conference in Chicago.
The post Navigating Opportunities and Challenges in the GLP-1 Drug Gold Rush appeared first on MedCity News.
Leave a comment